Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression After Coronary Bypass Surgery in Diabetic Patients

NCT00169832 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT00169832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00169832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Randomized Double-Blind Trial Comparing Rosiglitazone to Placebo for the Prevention of Atherosclerosis Progression After Coronary Bypass Surgery in Diabetic Patients
Lead sponsor
Laval University
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
July 31, 2007
Enrollment
193 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass grafting, diabetes